Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 8;89:361-379.
doi: 10.1016/j.pnpbp.2018.10.010. Epub 2018 Oct 17.

The Hypothalamic-Pituitary-Adrenal Axis in PTSD: Pathophysiology and Treatment Interventions


The Hypothalamic-Pituitary-Adrenal Axis in PTSD: Pathophysiology and Treatment Interventions

Boadie W Dunlop et al. Prog Neuropsychopharmacol Biol Psychiatry. .


Questions of how altered functioning of the hypothalamic pituitary adrenal (HPA) axis contribute to the development and maintenance of posttraumatic stress disorder (PTSD) have been the focus of extensive animal and human research. As a rule, results have been inconsistent across studies, likely due to a variety of confounding variables that have received inadequate attention. Important confounding factors include the effects of early life stress, biological sex, and the glucocorticoid used for interventions. In this manuscript we review: 1) the literature on identified abnormalities of HPA axis function in PTSD, both in terms of basal functioning and as part of challenge paradigms; 2) the role of HPA axis function pre- and immediately post-trauma as a risk factor for PTSD development; 3) the impact of HPA axis genes' allelic variants and epigenetic modifications on PTSD risk; 4) the contributions of HPA axis components to fear learning and extinction; and 5) therapeutic manipulations of the HPA axis to both prevent and treat PTSD, including the role of glucocorticoids as part of medication enhanced psychotherapy.

Keywords: Corticotropin releasing hormone; Cortisol; Dexamethasone; Glucocorticoid; Memory; Trauma.

Similar articles

See all similar articles

Cited by 5 articles

Publication types

MeSH terms